*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
connect@ibb.gatech.edu - event inquiries
Summary Sentence: “Break into VC: Career and Fundraising” - Yi-Yen Chen, Ph.D. - Echo Investment Capital
Full Summary: No summary paragraph submitted.
Bio LaunchPad Seminar SeriesHelping GT entrepreneurs learn how to fund and commercialize their technology.
VIRTUAL EVENT!
REGISTER here for participation link
“Break into VC: Career and Fundraising”
Yi-Yen Chen, Ph.D.
Managing Director
Echo Investment Capital
Yi-Yen Chen, Ph.D. is the Managing Director at Echo Investment Capital. She has over 10 years of healthcare-related experience. Prior to joining Echo, she oversaw the US healthcare investment and portfolio management at WI Harper Group in San Francisco. She also worked in business development and drug licensing at Microbio Group in Taiwan. Chen was the R&D project head and led the development of the world’s biggest antibody portfolio for the zebrafish research community at GeneTex.
Chen completed her Ph.D. in developmental biology from Nobel Laureate Professor Christiane Nüsslein-Volhard’s lab at the Max-Planck Institute in Germany. Her postdoctoral training was in molecular biology at the Institute of Molecular Biology in Mainz, Germany, and in cancer immunotherapy at the Netherlands Cancer Institute in Amsterdam.
The series is hosted by Georgia Tech's Institute for Bioengineering and Bioscience (IBB) and VentureLab. For inquiries or suggestions about future seminars, contact Cynthia Sundell, Senior Director of Life Sciences, IBB, or Harold Solomon, Principal, VentureLab.
